i
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — U.S. March–April 2021
-
04/30/2021
Details:
-
Corporate Authors:
-
Description:Suppl.EMENTARY TABLE. Demographic characteristics of v-safe respondents who received Janssen COVID-19 vaccine and completed at least one health survey during the 7 days after vaccination, March 2–April 12, 2021
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +